Search - tctmd.com

Displaying 421 - 440 of 3616

Sort: Relevancy | Date

News Conference News TVT 2016

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

Michael O'Riordan

June 18, 2016

Presentation TVT 2016

The Sentinel US Pivotal Clinical Trial Design

Presenter: Susheel Kodali

June 17, 2016

Presentation TVT 2016

The Sentinel Dual Filter Device: Design Features and EU Clinical Trial Results

Presenter: Nicolas M. Van Mieghem

June 17, 2016

News Featured Fellow

Kusum Lata, MD

Yael L. Maxwell

June 17, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

News Conference News TVT 2016

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Shelley Wood

June 17, 2016

News Industry News

Capricor Therapeutics Reports Positive 12-Month Data from the DYNAMIC Clinical Trial

June 17, 2016

News Features

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

Caitlin E. Cox

June 17, 2016

Presentation TVT 2016

Study Design for the PARTNER 3 Low-Risk Trial

Presenter: Martin B. Leon

June 16, 2016

Presentation TVT 2016

Study Design for the EVOLUT R Low-Risk Trial

Presenter: Jeffrey J. Popma

June 16, 2016

Presentation TVT 2016

Updates From NOTION: The First All-Comer TAVR Trial

Presenter: Lars Sondergaard

June 16, 2016

Presentation TVT 2016

The ACURATE TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: Thomas Walther

June 16, 2016

Presentation TVT 2016

The PORTICO TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: Ganesh Manoharan

June 16, 2016

Presentation TVT 2016

The DIRECT FLOW TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: Azeem Latib

June 16, 2016

Presentation TVT 2016

The EVOLUT R TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: James B. Hermiller Jr

June 16, 2016

Presentation TVT 2016

The SAPIEN 3 TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: Susheel Kodali

June 16, 2016

News Daily News

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

Todd Neale

June 16, 2016

News Daily News

Experts Agree: Lower Blood Pressure Is Better, but What’s a Realistic Target?

Todd Neale

June 15, 2016

News Daily News

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

Yael L. Maxwell

June 15, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

Advertisement

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

The Sentinel US Pivotal Clinical Trial Design

The Sentinel Dual Filter Device: Design Features and EU Clinical Trial Results

Kusum Lata, MD

What TAVR Needs Next . . . and What It’s Getting

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Capricor Therapeutics Reports Positive 12-Month Data from the DYNAMIC Clinical Trial

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

Study Design for the PARTNER 3 Low-Risk Trial

Study Design for the EVOLUT R Low-Risk Trial

Updates From NOTION: The First All-Comer TAVR Trial

The ACURATE TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

The PORTICO TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

The DIRECT FLOW TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

The EVOLUT R TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

The SAPIEN 3 TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

Experts Agree: Lower Blood Pressure Is Better, but What’s a Realistic Target?

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content